2022
DOI: 10.26226/m.6320ba64f30377bc3baf5f25
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

LB033 - Clinical trial using dermal open flow microperfusion (dOFM) elucidates mechanisms of dupilumab (Dupixent) on downstream signal pathways and indicates differences in local and systemic effects

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
references
References 0 publications
0
0
0
Order By: Relevance